TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Brii Biosciences Limited ( (HK:2137) ) just unveiled an announcement.
Brii Biosciences Limited has updated the terms of reference for its Nomination Committee, which is responsible for identifying and recommending candidates for the company’s board of directors. The committee’s structure and operational guidelines emphasize diversity and independence, aiming to enhance the board’s performance and governance, reflecting the company’s commitment to robust corporate governance practices.
The most recent analyst rating on (HK:2137) stock is a Hold with a HK$1.50 price target. To see the full list of analyst forecasts on Brii Biosciences Limited stock, see the HK:2137 Stock Forecast page.
More about Brii Biosciences Limited
Brii Biosciences Limited is a biotechnology company incorporated in the Cayman Islands, focusing on developing innovative therapies for infectious diseases and other significant health challenges.
YTD Price Performance: 85.71%
Average Trading Volume: 6,262,588
Technical Sentiment Signal: Sell
Current Market Cap: HK$1.34B
See more insights into 2137 stock on TipRanks’ Stock Analysis page.